Results 1 to 10 of about 14,095,140 (255)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model

Microorganisms, 2021
Influenza A and B viruses cause significant morbidity and mortality worldwide. Current influenza vaccines are composed of three or four strains: A/H1N1, A/H3N2, and B (Victoria and Yamagata lineages).
Ekaterina Stepanova, Elena Krutikova, Pei-Fong Wong, Victoria Matyushenko, Ekaterina Bazhenova, Irina Isakova-Sivak, Larisa Rudenko   +6 more
doaj   +1 more source

Influenza virus in human exhaled breath: an observational study. [PDF]

PLoS ONE, 2008
Recent studies suggest that humans exhale fine particles during tidal breathing but little is known of their composition, particularly during infection.We conducted a study of influenza infected patients to characterize influenza virus and particle ...
Patricia Fabian, James J McDevitt, Wesley H DeHaan, Rita O P Fung, Benjamin J Cowling, Kwok Hung Chan, Gabriel M Leung, Donald K Milton   +7 more
doaj   +1 more source

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice

Frontiers in Immunology, 2021
Influenza viruses undergo antigenic changes in the immuno-dominant hemagglutinin (HA) head domain, necessitating annual re-formulation of and re-vaccination with seasonal influenza virus vaccines for continuing protection.
Yonghong Liu, Shirin Strohmeier, Irene González-Domínguez, Jessica Tan, Jessica Tan, Viviana Simon, Viviana Simon, Viviana Simon, Viviana Simon, Florian Krammer, Florian Krammer, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Adolfo García-Sastre, Peter Palese, Peter Palese, Weina Sun   +18 more
doaj   +1 more source

Influenza B Virus: Some Features of Clinical Findings and Etiotropic Treatment

Журнал инфектологии, 2014
Since January 1997 till March 2009 492 patients with a confirmed diagnosis of influenza A virus and influenza B virus underwent work-up in Military Medical Academy.
O. V. Maltsev, I. S. Grishin, E. V. Peredelsky, N. I. Lvov, K. V. Zhdanov   +4 more
doaj   +1 more source

Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014. [PDF]

PLoS ONE, 2015
Influenza B virus remains a major contributor to the seasonal influenza outbreak and its prevalence has increased worldwide. We investigated the epidemiology and analyzed the full genome sequences of influenza B virus strains in Thailand between 2010 and
Nipaporn Tewawong, Kamol Suwannakarn, Slinporn Prachayangprecha, Sumeth Korkong, Preeyaporn Vichiwattana, Sompong Vongpunsawad, Yong Poovorawan   +6 more
doaj   +1 more source

Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export

Cell Reports, 2019
Summary: Naproxen is a non-steroidal anti-inflammatory drug that has previously been shown to exert antiviral activity against influenza A virus by inhibiting nucleoprotein (NP) binding to RNA.
Weinan Zheng, Wenhui Fan, Shuang Zhang, Pengtao Jiao, Yingli Shang, Liang Cui, Madina Mahesutihan, Jing Li, Dayan Wang, George Fu Gao, Lei Sun, Wenjun Liu   +11 more
doaj   +1 more source

Epidemiological and Virological Characterization of Influenza B Virus Infections.

PLoS ONE, 2016
While influenza A viruses comprise a heterogeneous group of clinically relevant influenza viruses, influenza B viruses form a more homogeneous cluster, divided mainly into two lineages: Victoria and Yamagata.
Sivan Sharabi, Yaron Drori, Michal Micheli, Nehemya Friedman, Sara Orzitzer, Ravit Bassal, Aharona Glatman-Freedman, Tamar Shohat, Ella Mendelson, Musa Hindiyeh, Michal Mandelboim   +10 more
doaj   +1 more source

Mouse-adapted influenza B virus for in vitro and in vivo assessment of therapeutic and preventive efficacy of antiviral drugs

Журнал инфектологии, 2019
Objective: to develop a new antigenic relevance influenza B virus suitable for modeling influenza infection in mice to assess of in vivo and in vitro therapeutic and preventive efficacy of antiviral drugs.Materials and methods: was carried out an ...
E. A. Prokopyeva, O. G. Kurskaya, M. V. Solomatina, I. A. Sobolev, Т. A. Murashkina, А. A. Derko, K. V. Korchagina, A. Yu. Yunusova, A. Yu. Alekseev, A. М. Shestopalov, S. V. Sysolyatin, A. В. Vorozhtsov, О. Е. Vaizova, E. Yu. Sherstoboev, К. A. Sharshov, А. М. Dygai   +15 more
doaj   +1 more source

Acute Respiratory Distress Syndrome Caused by Influenza B Virus Infection in a Patient with Diffuse Large B-Cell Lymphoma

Case Reports in Medicine, 2011
Influenza B virus infections are less common than infections caused by influenza A virus in critically ill patients, but similar mortality rates have been observed for both influenza types.
Silvio A. Ñamendys-Silva, María O. González-Herrera, Julia Texcocano-Becerra, Angel Herrera-Gómez   +3 more
doaj   +1 more source

The Influenza B Virus Victoria and Yamagata Lineages Display Distinct Cell Tropism and Infection-Induced Host Gene Expression in Human Nasal Epithelial Cell Cultures

Viruses, 2023
Understanding Influenza B virus infections is of critical importance in our efforts to control severe influenza and influenza-related diseases. Until 2020, two genetic lineages of influenza B virus—Yamagata and Victoria—circulated in the population ...
Jo L. Wilson, Elgin Akin, Ruifeng Zhou, Anne Jedlicka, Amanda Dziedzic, Hsuan Liu, Katherine Z. J. Fenstermacher, Richard E. Rothman, Andrew Pekosz   +8 more
doaj   +1 more source